Product Development
Jiangsu Rec-Biotechnology has vaccines represented by recombinant COVID-19 vaccine, HPV vaccine series, and herpes zoster virus vaccine
Multiple product lines with market capacity of tens of billions are at different stages of industrialization, and many subsequent innovation platforms and product series are planned to be gradually developed.
Product Categories
your location:
There is currently no content to display
Please add data record on website background.
  • TOP   

Contact Us


Time of issue:2022-03-29 08:59:20

Jiangsu Recbio Technology Co., Ltd.

Media Inquiry:

Investor Inquiry:


Address: Vaccine Engineering Center, China Medical City, Taizhou

Copyright © 2020 Jiangsu Rec-Biotechnology Co., Ltd.  All rights reserved.      苏ICP备19043567号-1